NUS Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
311.0M
-2.8%
320.1M
-0.2%
320.6M
-13.4%
370.3M
+1.7%
364.2M
Cost of Revenue
108.8M
+6.9%
101.8M
-4.1%
106.1M
-2.0%
108.3M
+0.8%
107.5M
Gross Profit
202.2M
-7.4%
218.3M
+1.8%
214.5M
-18.1%
262.0M
+2.0%
256.7M
Operating Expenses
197.1M
-29.0%
277.6M
+31.9%
210.4M
-11.9%
238.7M
+1.6%
235.1M
R&D
0
0
0
0
0
SG&A
197.1M
-0.8%
198.8M
-4.7%
208.6M
-12.6%
238.7M
+1.6%
235.1M
Operating Income
5.1M
+108.6%
-59319000
-1573.4%
4.0M
-82.7%
23.2M
+7.4%
21.6M
EBITDA
17.6M
-45.3%
32.2M
+76.9%
18.2M
-49.6%
36.2M
+7.2%
33.7M
Net Income
-742000
+99.7%
-249798000
-13705.6%
1.8M
-87.3%
14.5M
-15.2%
17.1M
EPS (Basic)
$-0.02
+99.6%
$-5.14
-12950.0%
$0.04
-86.7%
$0.30
-14.3%
$0.35
EPS (Diluted)
$-0.02
+99.6%
$-5.14
-12950.0%
$0.04
-85.7%
$0.28
-17.6%
$0.34
Shares (Diluted)
48.7M
+0.2%
48.6M
-1.7%
49.4M
-3.2%
51.1M
+1.5%
50.3M
NuSkin Enterprises (NUS) — Financials